To address the foregoing research gaps, the current study aimed to prospectively investigate the associations of serum IGF-1 concentrations with the risk of some brain-related disorders (dementia, stroke, and PD) using more than 0.3 million middle-aged and older participants in the UK Biobank cohort. Here, IGF1 is linked to Parkinson disease.